|
||
J. Cell Biol.,
Volume 143, Number 1, October 5, 1998 81-94

* Medical Research Council Laboratory for Molecular Cell Biology, University College London, WC1E 6BT London, United
Kingdom; The transcytotic pathway followed by the
polymeric IgA receptor (pIgR) carrying its bound
ligand (dIgA) from the basolateral to the apical surface
of polarized MDCK cells has been mapped using morphological tracers. At 20°C dIgA-pIgR internalize to interconnected groups of vacuoles and tubules that
comprise the endosomal compartment and in which
they codistribute with internalized transferrin receptors
(TR) and epidermal growth factor receptors (EGFR).
Upon transfer to 37°C the endosome vacuoles develop
long tubules that give rise to a distinctive population of
100-nm-diam cup-shaped vesicles containing pIgR. At
the same time, the endosome gives rise to multivesicular endosomes (MVB) enriched in EGFR and to
60-nm-diam basolateral vesicles. The cup-shaped vesicles carry the dIgA/pIgR complexes to the apical surface where they exocytose.
Using video microscopy and correlative electron microscopy to study cells grown thin and flat we show that
endosome vacuoles tubulate in response to dIgA/pIgR
but that the tubules contain TR as well as pIgR. However, we show that TR are removed from these dIgA-induced tubules via clathrin-coated buds and, as a result, the cup-shaped vesicles to which the tubules give
rise become enriched in dIgA/pIgR.
Taken together with the published information available on pIgR trafficking signals, our observations suggest that the steady-state concentrations of TR and
unoccupied pIgR on the basolateral surface of polarized MDCK cells are maintained by a signal-dependent, clathrin-based sorting mechanism that operates
along the length of the transcytotic pathway. We propose that the differential sorting of occupied receptors
within the MDCK endosome is achieved by this clathrin-based mechanism continuously retrieving receptors like TR from the pathways that deliver pIgR to the apical surface and EGFR to the lysosome.
Swiss Institute for Experimental Cancer Research and Institute for Biochemistry, University of Lausanne, CH-1066
Epalinges, Switzerland; and § Department of Cancer Biology, The Salk Institute for Biological Studies, San Diego, California,
92186-5800
|
|